NATURAL HEALTH TRENDS CORP (NHTC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 70M 140M 210M Q4 '17: 197.6M Q1 '18: 190.1M Q2 '18: 189.5M Q3 '18: 196.4M Q4 '18: 191.9M Q1 '19: 158.9M Q2 '19: 131.4M Q3 '19: 101.4M Q4 '19: 77.6M Q1 '20: 73.2M Q2 '20: 66.2M Q3 '20: 63.3M Q4 '20: 62.1M Q1 '21: 60.6M Q2 '21: 60.3M Q3 '21: 60.5M Q4 '21: 60M Q1 '22: 58.1M Q2 '22: 55.3M Q3 '22: 52.7M Q4 '22: 49.1M Q1 '23: 49.4M Q2 '23: 46.6M Q3 '23: 45.5M Q4 '23: 43.9M Q1 '24: 43M Q2 '24: 43M Q3 '24: 43.1M Q4 '24: 43M Q1 '25: 42.7M Q2 '25: 42.1M Q3 '25: 40.9M Q4 '25: 39.8M Q1 '26: 38.2M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Gross Profit TTM

0 90M 180M 270M Q4 '10: 16.6M Q1 '11: 15.9M Q2 '11: 16.8M Q3 '11: 21.2M Q4 '11: 23M Q1 '12: 26M Q2 '12: 28.9M Q3 '12: 27.8M Q4 '12: 27.8M Q1 '13: 27.6M Q2 '13: 27.5M Q3 '13: 31.4M Q4 '13: 40M Q1 '14: 51.5M Q2 '14: 70.1M Q3 '14: 84.4M Q4 '14: 97.6M Q1 '15: 111.5M Q2 '15: 140.4M Q3 '15: 180.1M Q4 '15: 210.8M Q1 '16: 239M Q2 '16: 248.8M Q3 '16: 241M Q4 '16: 232.8M Q1 '17: 221.4M Q2 '17: 197.7M Q3 '17: 172.6M Q4 '17: 158.9M Q1 '18: 152.4M Q2 '18: 151.3M Q3 '18: 156.4M Q4 '18: 152.5M Q1 '19: 124.5M Q2 '19: 102M Q3 '19: 77.5M Q4 '19: 57.5M Q1 '20: 53.8M Q2 '20: 47.4M Q3 '20: 45.2M Q4 '20: 45.1M Q1 '21: 44.9M Q2 '21: 45.5M Q3 '21: 45.6M Q4 '21: 45M Q1 '22: 43.4M Q2 '22: 41.2M Q3 '22: 39.2M Q4 '22: 36.5M Q1 '23: 36.7M Q2 '23: 34.5M Q3 '23: 33.9M Q4 '23: 32.7M Q1 '24: 32M Q2 '24: 31.9M Q3 '24: 31.9M Q4 '24: 31.8M Q1 '25: 31.7M Q2 '25: 31.1M Q3 '25: 30.2M Q4 '25: 29.3M Q1 '26: 28.3M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Operating Income TTM

-25M 0 25M 50M 75M Q4 '10: -3.1M Q1 '11: -2.6M Q2 '11: -1.1M Q3 '11: 979K Q4 '11: 1.8M Q1 '12: 2.7M Q2 '12: 2.9M Q3 '12: 2.5M Q4 '12: 2.6M Q1 '13: 2.4M Q2 '13: 2.4M Q3 '13: 3M Q4 '13: 4.2M Q1 '14: 7M Q2 '14: 12.3M Q3 '14: 16.4M Q4 '14: 20.8M Q1 '15: 24.6M Q2 '15: 30.7M Q3 '15: 40.1M Q4 '15: 47.9M Q1 '16: 54.9M Q2 '16: 57.6M Q3 '16: 58M Q4 '16: 64.1M Q1 '17: 63.1M Q2 '17: 61.1M Q3 '17: 54.4M Q4 '17: 43.1M Q1 '18: 40.1M Q2 '18: 37.4M Q3 '18: 36.7M Q4 '18: 33.7M Q1 '19: 21M Q2 '19: 10.9M Q3 '19: 2M Q4 '19: -7M Q1 '20: -5.8M Q2 '20: -5.6M Q3 '20: -3.8M Q4 '20: 669K Q1 '21: 2.3M Q2 '21: 2.5M Q3 '21: 2.4M Q4 '21: 1.6M Q1 '22: 968K Q2 '22: 798K Q3 '22: 174K Q4 '22: -270K Q1 '23: -281K Q2 '23: -1.2M Q3 '23: -1.4M Q4 '23: -1.7M Q1 '24: -1.6M Q2 '24: -1.1M Q3 '24: -1.1M Q4 '24: -1.3M Q1 '25: -1.3M Q2 '25: -1.4M Q3 '25: -1.6M Q4 '25: -1.8M Q1 '26: -1.9M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Net Income TTM

-20M 0 20M 40M 60M Q4 '10: -2.4M Q1 '11: -2.1M Q2 '11: -913K Q3 '11: 1.5M Q4 '11: 2.3M Q1 '12: 3.3M Q2 '12: 3.5M Q3 '12: 2.6M Q4 '12: 2.6M Q1 '13: 2.4M Q2 '13: 2.5M Q3 '13: 3M Q4 '13: 4.1M Q1 '14: 6.9M Q2 '14: 12.1M Q3 '14: 16.1M Q4 '14: 20.4M Q1 '15: 24M Q2 '15: 30.2M Q3 '15: 39.3M Q4 '15: 47.2M Q1 '16: 51.8M Q2 '16: 51.7M Q3 '16: 49.7M Q4 '16: 55.1M Q1 '17: 54.2M Q2 '17: 52.3M Q3 '17: 47.1M Q4 '18: 31M Q1 '19: 20.3M Q2 '19: 11.7M Q3 '19: 2.8M Q4 '19: -5.6M Q1 '20: -4.3M Q2 '20: -4.6M Q3 '20: -2.7M Q4 '20: 843K Q1 '21: 1.6M Q2 '21: 1.8M Q3 '21: 1.6M Q4 '21: 1.1M Q1 '22: 827K Q2 '22: 781K Q3 '22: 357K Q4 '22: 313K Q1 '23: 675K Q2 '23: 273K Q3 '23: 398K Q4 '23: 568K Q1 '24: 499K Q2 '24: 891K Q3 '24: 754K Q4 '24: 572K Q1 '25: 506K Q2 '25: 348K Q3 '25: -118K Q4 '25: -882K Q1 '26: -1.2M Q1 '11 Q1 '13 Q1 '15 Q1 '17 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Cost of Revenue TTM

0 15M 30M 45M Q4 '17: 38.6M Q1 '18: 37.6M Q2 '18: 38.2M Q3 '18: 40M Q4 '18: 39.4M Q1 '19: 34.4M Q2 '19: 29.4M Q3 '19: 23.8M Q4 '19: 20.1M Q1 '20: 19.4M Q2 '20: 18.8M Q3 '20: 18.1M Q4 '20: 17M Q1 '21: 15.7M Q2 '21: 14.8M Q3 '21: 14.9M Q4 '21: 15M Q1 '22: 14.7M Q2 '22: 14.1M Q3 '22: 13.6M Q4 '22: 12.7M Q1 '23: 12.8M Q2 '23: 12.1M Q3 '23: 11.6M Q4 '23: 11.2M Q1 '24: 11.1M Q2 '24: 11.1M Q3 '24: 11.2M Q4 '24: 11.2M Q1 '25: 11.1M Q2 '25: 11M Q3 '25: 10.7M Q4 '25: 10.5M Q1 '26: 10M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Operating Cash Flow TTM

-30M 0 30M 60M 90M Q4 '11: 1.5M Q1 '12: 2.3M Q2 '12: 3.5M Q3 '12: 1.6M Q4 '12: 2.2M Q1 '13: 2.4M Q2 '13: 2.2M Q3 '13: 5.7M Q4 '13: 10.7M Q1 '14: 18M Q2 '14: 20.9M Q3 '14: 26.5M Q4 '14: 30.6M Q1 '15: 38.9M Q2 '15: 57.3M Q3 '15: 74.9M Q4 '15: 81.3M Q1 '16: 78.6M Q2 '16: 72.3M Q3 '16: 52.4M Q4 '16: 53.2M Q1 '17: 53.2M Q2 '17: 43.4M Q3 '17: 32.2M Q4 '17: 26.6M Q1 '18: 23.9M Q2 '18: 22.5M Q3 '18: 36.5M Q4 '18: 29.7M Q1 '19: 7.2M Q2 '19: -1.8M Q3 '19: -14.3M Q4 '19: -18.6M Q1 '20: -8.3M Q2 '20: -4.6M Q3 '20: -1.4M Q4 '20: 1.9M Q1 '21: 3.3M Q2 '21: 3.5M Q3 '21: 2.9M Q4 '21: 1M Q1 '22: -1.7M Q2 '22: -3M Q3 '22: -4.2M Q4 '22: -4.9M Q1 '23: -3.2M Q2 '23: -4.7M Q3 '23: -3.3M Q4 '23: -4.3M Q1 '24: -3M Q2 '24: -4M Q3 '24: -3.5M Q4 '24: -3.4M Q1 '25: -3.4M Q2 '25: -5.5M Q3 '25: -5M Q4 '25: -6M Q1 '26: -7.3M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Free Cash Flow TTM

-30M 0 30M 60M 90M Q4 '11: 1.5M Q1 '12: 2.2M Q2 '12: 3.4M Q3 '12: 1.5M Q4 '12: 2.1M Q1 '13: 2.3M Q2 '13: 2.1M Q3 '13: 5.7M Q4 '13: 10.5M Q1 '14: 17.7M Q2 '14: 20.7M Q3 '14: 26.2M Q4 '14: 30.3M Q1 '15: 38.3M Q2 '15: 56.7M Q3 '15: 74.1M Q4 '15: 80.6M Q1 '16: 77.9M Q2 '16: 71.4M Q3 '16: 51.7M Q4 '16: 52.3M Q1 '17: 52.4M Q2 '17: 42.8M Q3 '17: 31.8M Q4 '17: 26.3M Q1 '18: 23.7M Q2 '18: 22.2M Q3 '18: 36.3M Q4 '18: 29.5M Q1 '19: 7M Q2 '19: -2.1M Q3 '19: -14.5M Q4 '19: -18.8M Q1 '20: -8.4M Q2 '20: -4.7M Q3 '20: -1.6M Q4 '20: 1.7M Q1 '21: 3M Q2 '21: 3.2M Q3 '21: 2.6M Q4 '21: 791K Q1 '22: -1.9M Q2 '22: -3.2M Q3 '22: -4.4M Q4 '22: -5M Q1 '23: -3.3M Q2 '23: -4.8M Q3 '23: -3.3M Q4 '23: -4.3M Q1 '24: -3.1M Q2 '24: -4M Q3 '24: -3.6M Q4 '24: -3.4M Q1 '25: -3.5M Q2 '25: -5.5M Q3 '25: -5M Q4 '25: -6.1M Q1 '26: -7.4M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q2 '10: 10.5M Q3 '10: 10.5M Q1 '11: 10.6M Q2 '11: 10.7M Q3 '11: 10.9M Q1 '12: 11.2M Q2 '12: 11.2M Q3 '12: 11.2M Q1 '13: 11.2M Q2 '13: 11.3M Q3 '13: 11.3M Q1 '14: 11.7M Q2 '14: 12.3M Q3 '14: 12.8M Q1 '15: 12.5M Q2 '15: 12.5M Q3 '15: 12.3M Q1 '16: 11.8M Q2 '16: 11.4M Q3 '16: 11.2M Q1 '17: 11.3M Q2 '17: 11.3M Q3 '17: 11.3M Q1 '18: 11.3M Q2 '18: 11.3M Q3 '18: 11.3M Q1 '19: 11.3M Q2 '19: 11.1M Q3 '19: 10.6M Q1 '20: 10.5M Q2 '20: 11.4M Q3 '20: 11.4M Q1 '21: 11.4M Q2 '21: 11.4M Q3 '21: 11.4M Q1 '22: 11.3M Q2 '22: 11.4M Q3 '22: 11.4M Q1 '23: 11.4M Q2 '23: 11.4M Q3 '23: 11.5M Q1 '24: 11.5M Q2 '24: 11.5M Q3 '24: 11.5M Q1 '25: 11.5M Q2 '25: 11.5M Q3 '25: 11.5M Q1 '26: 10.1M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.00 0.00 2.00 4.00 6.00 Q4 '10: -0.23 Q1 '11: -0.19 Q2 '11: -0.08 Q3 '11: 0.14 Q4 '11: 0.21 Q1 '12: 0.29 Q2 '12: 0.31 Q3 '12: 0.23 Q4 '12: 0.23 Q1 '13: 0.22 Q2 '13: 0.22 Q3 '13: 0.27 Q4 '13: 0.37 Q1 '14: 0.60 Q2 '14: 1.01 Q3 '14: 1.31 Q4 '14: 1.62 Q1 '15: 1.90 Q2 '15: 2.39 Q3 '15: 3.15 Q4 '15: 3.82 Q1 '16: 4.23 Q2 '16: 4.32 Q3 '16: 4.26 Q4 '16: 4.83 Q1 '17: 4.81 Q2 '17: 4.65 Q3 '17: 4.18 Q4 '18: 2.74 Q1 '19: 1.79 Q2 '19: 1.03 Q3 '19: 0.24 Q4 '19: -0.52 Q1 '20: -0.40 Q2 '20: -0.44 Q3 '20: -0.26 Q4 '20: 0.07 Q1 '21: 0.13 Q2 '21: 0.15 Q3 '21: 0.13 Q4 '21: 0.09 Q1 '22: 0.07 Q2 '22: 0.07 Q3 '22: 0.03 Q4 '22: 0.03 Q1 '23: 0.06 Q2 '23: 0.02 Q3 '23: 0.04 Q4 '23: 0.05 Q1 '24: 0.05 Q2 '24: 0.09 Q3 '24: 0.07 Q4 '24: 0.06 Q1 '25: 0.05 Q2 '25: 0.03 Q3 '25: -0.01 Q4 '25: -0.08 Q1 '26: -0.11 Q1 '11 Q1 '13 Q1 '15 Q1 '17 Q1 '20 Q1 '22 Q1 '24 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.